Labiotech.eu - Europe's leading Biotech News Website

Latest Posts

News and Trends 17 Mar 2016

GSK partners to Scale Manufacturing of CAR-T Therapies

Production of CAR-T therapies seems to be one of the biggest challenge of this promising technology. Miltenyi Biotec (Germany) and GSK have entered a new partnership to combine the clinical development of cell and gene therapies with manufacturing expertise. Milteniy is a German company of 1600 employees developing products for biomedical research and cellular therapy. It’s not the first […]

March 17, 2016 - 3 minutesmins - By Denise Neves Gameiro

News and Trends 17 Mar 2016

A Relief for Migraines at last? The Biotech race for the Ultimate Cure

A Migraine is more than just a headache; it is a neurological disorder affecting a staggering 10% of the worldwide population. So where are we on fighting a viable therapy – and who is working on Migraines? People of all ages are at risk of migraine, with women being three times more likely to suffer from […]

March 17, 2016 - 4 minutesmins - By Ekaterina Perets

News and Trends 16 Mar 2016

‘Cyborg’ Heart Patch to Revolutionize Treatment of Heart Attacks

Researchers from Tel Aviv University (Israel) have managed to engineer a Nanotech ‘heart patch’ which could enable remote monitoring and regulation of a patient’s heart – bionic! MedTech continues to blur the boundary between man and machine. A new project combines organic, living tissue and a complex nanoelectronic system to create a bionic heart patch that could help […]

March 16, 2016 - 3 minutesmins - By Denise Neves Gameiro

News and Trends 16 Mar 2016

How Good was 2015 for the French Universal CAR-T Biotech?

Cellectis (France) has now released its financial results for 2015. What happened and what the prospects for 2016 and long-term? It was a really packed year for Cellectis, the French Champion for universal, off-the-shelf CAR-T treatments. The Biopharma saw significant advances in multiple fronts, from clinical development to financing. The first therapy initially developed by […]

March 16, 2016 - 3 minutesmins - By Denise Neves Gameiro

News and Trends 16 Mar 2016

Interviewing the Biotech which raised the Biggest European Round in 2016 so far

Yesterday I flew to Switzerland for the day, to gage what was going on at the 9th Annual Sachs conference for European Biotech CEOs. Here I had the chance to Interview Cambridge UK’s Mission Therapeutics on investment and technology.. Panel discussions covered Partnering and Investment for various therapeutic platforms – in MedTech, Diagnostics and generally ‘Israel’ (and […]

March 16, 2016 - 1 minutemin - By Philip Hemme

News and Trends 15 Mar 2016

French SynBio Biotech to ferment wood for Carbon-free Future

Deinove (Montpelier) and Arbiom (Evry) are two Biotechs from France which have now partnered to transform wood residues into added-value chemicals – a step closer to the ideal Bioeconomy. Deinove is one of our favourite Green Chemistry and SynBio Biotechs, developing micro-factories with their library of Deinococcus. Its projects range from using tobacco plants to making carotenoids, also with […]

March 15, 2016 - 3 minutesmins - By Denise Neves Gameiro

ADVERTISEMENT

News and Trends 15 Mar 2016

French Nanomedicine Biotech Gets €21M to Kill Cancer with ‘Beam Rays’

Nanobiotix (France) has had a successful private placement in, raising €21.3M to advance the clinical development of its localised radiotherapy for Cancer. Located in Paris’ superbiocluster, Nanobiotix wants to change the way cancer is treated – but in a different way from most Biotech strategies. It is developing NanoXRay, a paradigm-shifting nanotechnology for localised radiotherapy. Nanobiotix has […]

March 15, 2016 - 2 minutesmins - By Denise Neves Gameiro

News and Trends 15 Mar 2016

How will the UK’s Potential Exit from the EU Affect the Biotech Industry?

I’m a UK Expat in Berlin, and whilst I admit confusion over where exactly the British Exit (i.e. “Brexit”) will leave me in the future, in general it is a depressing thought – for the UK Biotech Industry also. What exactly are the Industry logistics for the UK detaching itself from the EU? Admittedly there […]

March 15, 2016 - 6 minutesmins - By Dani Bancroft

News and Trends 14 Mar 2016

British Startup Raises Millions to Become the Illumina for Epigenetics

Cambridge Epigenetix (UK) wants to unlock the power of the Epigenome and become what Illumina is for NGS. And now, it has gotten the €18.9M and a new CEO needed to achieve this. Cambrige Epigenetix is a Biotech developing epigenetic tools, and was initially founded by Cambridge Enterprise (an incubator of the University of Cambridge) and […]

March 14, 2016 - 3 minutesmins - By Denise Neves Gameiro

News and Trends 14 Mar 2016

Florida to release Genetically Engineered Mosquitoes to stop Zika Virus

Oxitec (UK) is on track to be allowed to trial their self-limiting, genetically engineered mosquitoes in the US – and stop the spread of Dengue and Zika. As a spin-off from Oxford University, Oxitec specialises in using genetic engineering to control insect pest populations with the ‘Sterile Insect Technique’. This is an interesting alternative to pesticides […]

March 14, 2016 - 3 minutesmins - By Denise Neves Gameiro

News and Trends 14 Mar 2016

5 Steps to Transform your Laboratory into an Automated Workspace!

Today’s laboratories work with a range of information sources – from samples, results, tests, storage, budget, client’s requests and so on. In this way, information finds itself at the heart of a lab, and is crucial for efficient research. Automation and digitalization of the workspace can therefore help labs to manage this large amount of information. Labiotech, in collaboration […]

March 14, 2016 - 7 minutesmins - By Joachim Eeckhout

News and Trends 14 Mar 2016

DBV: “These Additional Results Confirm our Potential of solving the Peanut Allergy problem Worldwide”

DBV Technologies (Paris) was just under the spotlight in Los Angeles at the biggest allergy convention worldwide (2016 AAAAI Annual Meeting). Their Viaskin skin patch could potentially eradicate peanut allergies for patients altogether… Last year, it was the first French Biotech to be listed on the NASDAQ (raising €90M), it then raised €255M (!) in a follow-up round […]

March 14, 2016 - 6 minutesmins - By Philip Hemme

ADVERTISEMENT